Patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family membersCentral MessagePerspective

Objective: Genetic aortopathy, if left untreated, leads to aortic catastrophe in most affected individuals. We sought to determine the genetic mutation patterns and detection rates in patients with aortopathy and their families with a systematic screening protocol. Methods: In 2016 to 2020, patients...

Full description

Bibliographic Details
Main Authors: Jihoon Kim, MD, PhD, Jae Suk Yoo, MD, PhD, Hee-Jung Kim, MD, PhD, Ho Jin Kim, MD, Dae-Hee Kim, MD, PhD, Suk Jung Choo, MD, PhD, Joon Bum Kim, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:JTCVS Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666273623001626
_version_ 1827807244359565312
author Jihoon Kim, MD, PhD
Jae Suk Yoo, MD, PhD
Hee-Jung Kim, MD, PhD
Ho Jin Kim, MD
Dae-Hee Kim, MD, PhD
Suk Jung Choo, MD, PhD
Joon Bum Kim, MD, PhD
author_facet Jihoon Kim, MD, PhD
Jae Suk Yoo, MD, PhD
Hee-Jung Kim, MD, PhD
Ho Jin Kim, MD
Dae-Hee Kim, MD, PhD
Suk Jung Choo, MD, PhD
Joon Bum Kim, MD, PhD
author_sort Jihoon Kim, MD, PhD
collection DOAJ
description Objective: Genetic aortopathy, if left untreated, leads to aortic catastrophe in most affected individuals. We sought to determine the genetic mutation patterns and detection rates in patients with aortopathy and their families with a systematic screening protocol. Methods: In 2016 to 2020, patients with aortic dissection or root aneurysm (Z score ≥2) and their first-degree relatives were enrolled in a prospective registry at a tertiary referral center. The individuals underwent systematic single- or multi-gene panel testing depending on clinical presentations. Results: Among 575 enrolled individuals (mean age, 46.6 ± 14.5 years; 203 women), 346 (60.2%) underwent genetic testing. Rates of relevant gene mutations identified were 39.4% (91/231), 27.1% (54/199) and 72.4% (n = 105) in aneurysm, dissection, and family screening groups, respectively (P < .001). Mutated genes frequently identified were FBN1 (n = 199; Marfan), TGFBR1/2 or SMAD3 (n = 14; Loeys-Dietz), COL3A1/COL5A2 (n = 15; Ehlers-Danlos), and ACTA2 (n = 10). After enrollment, 123 aortic surgeries were performed in 117 patients (20.3%) including 15 family members, with resultant operative mortality of 0.8% (n = 1). In logistic regression analysis, systemic score in Ghent nosology was the only significant factor associated with positive gene mutation (odds ratio, 14.81; 95% confidence interval, 6.87-31.96), and its 3.5 point cutoff showed the best predictive value with 78.2% sensitivity and 87.2% specificity. Conclusions: Genetic aortopathy was identified in a considerable proportion of patients with aortopathy and their family members by systematic genetic testing. This strategy is recommended for timely diagnosis and proactive management of genetic aortopathy.
first_indexed 2024-03-11T21:54:36Z
format Article
id doaj.art-48a4e60eb041474f9679397c6abb1e8c
institution Directory Open Access Journal
issn 2666-2736
language English
last_indexed 2024-03-11T21:54:36Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series JTCVS Open
spelling doaj.art-48a4e60eb041474f9679397c6abb1e8c2023-09-26T04:12:31ZengElsevierJTCVS Open2666-27362023-09-01152737Patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family membersCentral MessagePerspectiveJihoon Kim, MD, PhD0Jae Suk Yoo, MD, PhD1Hee-Jung Kim, MD, PhD2Ho Jin Kim, MD3Dae-Hee Kim, MD, PhD4Suk Jung Choo, MD, PhD5Joon Bum Kim, MD, PhD6Department of Thoracic and Cardiovascular Surgery, Hallym University Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Republic of KoreaDepartment of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Asan Genetic Aortopathy Clinic, Asan Aortic Disease Center, Asan Medical Center, Seoul, Republic of KoreaDepartment of Thoracic and Cardiovascular Surgery, Korea University Anam Hospital, Korea University, Seoul, Republic of KoreaDepartment of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Asan Genetic Aortopathy Clinic, Asan Aortic Disease Center, Asan Medical Center, Seoul, Republic of KoreaAsan Genetic Aortopathy Clinic, Asan Aortic Disease Center, Asan Medical Center, Seoul, Republic of Korea; Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of KoreaDepartment of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Asan Genetic Aortopathy Clinic, Asan Aortic Disease Center, Asan Medical Center, Seoul, Republic of KoreaDepartment of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Asan Genetic Aortopathy Clinic, Asan Aortic Disease Center, Asan Medical Center, Seoul, Republic of Korea; Address for reprints: Joon Bum Kim, MD, PhD, Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea.Objective: Genetic aortopathy, if left untreated, leads to aortic catastrophe in most affected individuals. We sought to determine the genetic mutation patterns and detection rates in patients with aortopathy and their families with a systematic screening protocol. Methods: In 2016 to 2020, patients with aortic dissection or root aneurysm (Z score ≥2) and their first-degree relatives were enrolled in a prospective registry at a tertiary referral center. The individuals underwent systematic single- or multi-gene panel testing depending on clinical presentations. Results: Among 575 enrolled individuals (mean age, 46.6 ± 14.5 years; 203 women), 346 (60.2%) underwent genetic testing. Rates of relevant gene mutations identified were 39.4% (91/231), 27.1% (54/199) and 72.4% (n = 105) in aneurysm, dissection, and family screening groups, respectively (P < .001). Mutated genes frequently identified were FBN1 (n = 199; Marfan), TGFBR1/2 or SMAD3 (n = 14; Loeys-Dietz), COL3A1/COL5A2 (n = 15; Ehlers-Danlos), and ACTA2 (n = 10). After enrollment, 123 aortic surgeries were performed in 117 patients (20.3%) including 15 family members, with resultant operative mortality of 0.8% (n = 1). In logistic regression analysis, systemic score in Ghent nosology was the only significant factor associated with positive gene mutation (odds ratio, 14.81; 95% confidence interval, 6.87-31.96), and its 3.5 point cutoff showed the best predictive value with 78.2% sensitivity and 87.2% specificity. Conclusions: Genetic aortopathy was identified in a considerable proportion of patients with aortopathy and their family members by systematic genetic testing. This strategy is recommended for timely diagnosis and proactive management of genetic aortopathy.http://www.sciencedirect.com/science/article/pii/S2666273623001626aortic dissectionEhlers-Danlos syndromegenetic aortopathyLoeys-Dietz syndromeMarfan syndromethoracic aortic aneurysm
spellingShingle Jihoon Kim, MD, PhD
Jae Suk Yoo, MD, PhD
Hee-Jung Kim, MD, PhD
Ho Jin Kim, MD
Dae-Hee Kim, MD, PhD
Suk Jung Choo, MD, PhD
Joon Bum Kim, MD, PhD
Patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family membersCentral MessagePerspective
JTCVS Open
aortic dissection
Ehlers-Danlos syndrome
genetic aortopathy
Loeys-Dietz syndrome
Marfan syndrome
thoracic aortic aneurysm
title Patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family membersCentral MessagePerspective
title_full Patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family membersCentral MessagePerspective
title_fullStr Patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family membersCentral MessagePerspective
title_full_unstemmed Patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family membersCentral MessagePerspective
title_short Patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family membersCentral MessagePerspective
title_sort patterns of genetic mutations explored by systematic screening of patients with aortopathy and their family memberscentral messageperspective
topic aortic dissection
Ehlers-Danlos syndrome
genetic aortopathy
Loeys-Dietz syndrome
Marfan syndrome
thoracic aortic aneurysm
url http://www.sciencedirect.com/science/article/pii/S2666273623001626
work_keys_str_mv AT jihoonkimmdphd patternsofgeneticmutationsexploredbysystematicscreeningofpatientswithaortopathyandtheirfamilymemberscentralmessageperspective
AT jaesukyoomdphd patternsofgeneticmutationsexploredbysystematicscreeningofpatientswithaortopathyandtheirfamilymemberscentralmessageperspective
AT heejungkimmdphd patternsofgeneticmutationsexploredbysystematicscreeningofpatientswithaortopathyandtheirfamilymemberscentralmessageperspective
AT hojinkimmd patternsofgeneticmutationsexploredbysystematicscreeningofpatientswithaortopathyandtheirfamilymemberscentralmessageperspective
AT daeheekimmdphd patternsofgeneticmutationsexploredbysystematicscreeningofpatientswithaortopathyandtheirfamilymemberscentralmessageperspective
AT sukjungchoomdphd patternsofgeneticmutationsexploredbysystematicscreeningofpatientswithaortopathyandtheirfamilymemberscentralmessageperspective
AT joonbumkimmdphd patternsofgeneticmutationsexploredbysystematicscreeningofpatientswithaortopathyandtheirfamilymemberscentralmessageperspective